Purchase Order 75N91018P00603

<p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. valued at $24,957.00 on March 14, 2019, for a service agreement with a firm fixed-price structure. No set-aside was used. Performance occurs in Bethesda, Maryland. The order carried an ultimate completion date of April 17, 2020. The specific scope of services is not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,035.00 on September 7, 2017, with an ultimate completion date of September 20, 2018. No set-aside was used. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed-price basis and procures flow cytometry instrumentation and associated support services. Sony Biotechnology operates as a prime contractor and does not use subcontractors on federal work.</p>

The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,811.78 on September 21, 2019, with an ultimate completion date of September 20, 2020. Work is performed in Bethesda, Maryland. The order covers flow cytometry instrumentation and support services for the CCR Scientific Research Community's core facility in Building 37, which operates five cell analyzers and four additional instruments for state-of-the-art cell analysis and sorting. Pricing is firm fixed...

<p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for system maintenance services valued at $152,280.00, effective July 19, 2026. The order covers a one-year period of performance through July 18, 2027 and carries a firm fixed-price structure with no small business set-aside. Work is performed in Bethesda, Maryland. The contract references quote HGO061126-01 and maintains an ultimate completion date of July 18, 2031.</p>

The National Cancer Institute issued a purchase order to Sony Biotechnology Inc. for $19,035.00 on October 29, 2018, under a maintenance service agreement with a period of performance from October 31, 2018 to October 30, 2019. Work is performed in San Jose, California. The order covers preventive maintenance and on-site support services for Sony cell sorting and flow cytometry instrumentation, including unlimited telephone and on-site support, software and firmware updates, and OEM-certified...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $19,035 purchase order to Sony Biotechnology Inc.'s San Jose, California division for maintenance services. The prime contractor, Sony Biotechnology Inc., will provide maintenance support under a firm fixed price contract running from September 21, 2023 through September 20, 2024. The award was made using the National Institutes of Health's internal funding to support the National...

Sony Biotechnology Inc. was awarded a $23,895 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The firm fixed price contract is for equipment maintenance services to be performed over a one year period from January 2024 through January 2025. The place of performance will be Sony Biotechnology's facility located in San Jose, California. No additional details were provided regarding the specific...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,750 purchase order to Sony Biotechnology Inc. for a service agreement for Sony MA900 cell sorters. The place of performance will be in Rockville, Maryland. The period of performance is one year, from July 1, 2023 through June 30, 2024. The contract pricing is firm fixed price. No additional details were provided regarding subcontractors or the National Cancer Institute's programs....

The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $311,403.80 on September 16, 2020. The order covers procurement of a Sony MA900 cell sorter with 488nm/405nm/561nm/638nm lasers, a 96/384 well plate deposition system (LE-MA900FP), and a biosafety cabinet for SH800/MA900 with AMS (BIO-02). Place of performance is San Jose, California. The order carried an ultimate completion date of December 15, 2020 and was issued on a firm fixed-price basis to de-obligate...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>